《美國股市》消化美國數據 道指轉跌逾300點
美國最新通脹數據放緩,美股今日高開,但隨後轉跌超過300點,截至香港時間凌晨0時29分,道指跌309點或0.91%,報33,601.48點。
莫德納(MRNA.US)升幅收窄,早市一度升超過7%,最新升逾3%,其呼吸道融合病毒(RSV)三期試驗數據,指其疫苗能預防老年人症狀達84%有效性,上半年申請監管許可。Tesla(TSLA.US)中國銷售推高,轉跌近2%。
納指及標普500指數跌幅較細,納指跌45點或0.41%,報11,049.49點;標普500指數跌23點或0.6%,報3,967.3點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.